<DOC>
	<DOCNO>NCT01872949</DOCNO>
	<brief_summary>The study design observe clinical outcome heart failure patient treat C-Pulse® System usual manner accord approve indication contraindication .</brief_summary>
	<brief_title>C-Pulse® System European Multicenter Study</brief_title>
	<detailed_description>Evaluation post-market clinical performance safety C-Pulse® System treatment Heart Failure population patient meet approved clinical condition provide indication contraindication .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient 18 year old Patients moderate severe ambulatory heart failure [ American College Cardiology/American Heart Association ( ACC/AHA ) Stage C ; NYHA Class III/IV ambulatory ] , refractory optimal medical therapy Patients nonresponders CRT pacemaker therapy Patient sign date investigation inform consent form Evidence significant ascend aortic calcification posteroanterior chest Xray CT scan Moderate severe atherosclerotic aortic disease Ascending aortocoronary artery bypass graft Any history aortic dissection Connective tissue disorder Marfans disease Aorta conform specify dimensional constraint Patient severe mitral valve incompetence , grade 4+ Patient moderate severe aortic valve incompetence , grade 2 4+ Patient systolic blood pressure le 90 great 140mmHg Presence active systemic infection Presence bleeding coagulation disorder ( relative )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>NYHA Class III</keyword>
	<keyword>NYHA Class IV</keyword>
</DOC>